Title:
VACCINE COMPOSITIONS COMPRISING MUTATED FACTOR H BINDING PROTEIN
Document Type and Number:
Japanese Patent JP2015063558
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide vaccine compositions comprising a mutated factor h binding protein.SOLUTION: The present invention relates to: an immunogenic composition comprising at least one modified factor H binding protein capable of eliciting an immune response, when administered to a human or non-human animal, and associated compositions; usages; and kits. According to a first embodiment, the present invention provides an immunogenic composition comprising at least one modified factor H binding protein capable of eliciting an immune response, when administered to a human or non-human animal. One aim of the invention is to provide one or more kinds of compositions which can be used to elicit a protective immune response against Neisseria meningitidis.
Inventors:
RACHEL EXLEY
CHRISTOPH TANG
SUSAN M LEA
CHRISTOPH TANG
SUSAN M LEA
Application Number:
JP2014261910A
Publication Date:
April 09, 2015
Filing Date:
December 25, 2014
Export Citation:
Assignee:
IMP INNOVETIONS LTD
International Classes:
A61K39/095; A61P31/04; A61P37/04; A61P43/00
Domestic Patent References:
| JP2008528597A | 2008-07-31 | |||
| JP2006503822A | 2006-02-02 |
Other References:
JPN6013064257; Ｔｈｅ Ｊｏｕｒｎａｌ ｏｆ Ｅｘｐｅｒｉｍｅｎｔａｌ Ｍｅｄｉｃｉｎｅ Ｖｏｌ．１９７， Ｎｏ．６, 2003, ｐ．７８９-７９９
JPN6013064258; Ｊｏｕｒｎａｌ ｏｆ Ｉｎｆｅｃｔｉｏｕｓ Ｄｉｓｅａｓｅｓ Ｖｏｌ．１９５， Ｎｏ．１０, 2007, ｐ．１４７２-１４７９
JPN6013064258; Ｊｏｕｒｎａｌ ｏｆ Ｉｎｆｅｃｔｉｏｕｓ Ｄｉｓｅａｓｅｓ Ｖｏｌ．１９５， Ｎｏ．１０, 2007, ｐ．１４７２-１４７９
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Natsuki Morishita
Previous Patent: 4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS
Next Patent: XBP1 PEPTIDE, CD138 PEPTIDE, AND CS1 PEPTIDE
Next Patent: XBP1 PEPTIDE, CD138 PEPTIDE, AND CS1 PEPTIDE